Biogen Idec shares owned by Beutel, Goodman & Company
Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Beutel, Goodman & Company
from 13F filings
Historical chart of Beutel, Goodman & Company investment in Biogen Idec
Tip: Access up to 7 years of quarterly data
All positions including Biogen Idec held by Beutel, Goodman & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biogen Idec by Beutel, Goodman & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $405M | 1.7M | 231.82 |
| 2024-03-31 | $338M | 1.6M | 215.63 |
| 2023-12-31 | $258M | 996k | 258.77 |
| 2023-09-30 | $257M | 999k | 257.01 |
| 2023-06-30 | $285M | 999k | 284.85 |
| 2023-03-31 | $272M | 978k | 278.03 |
| 2022-12-31 | $264M | 955k | 276.92 |
| 2022-09-30 | $256M | 958k | 267.00 |
| 2022-06-30 | $197M | 966k | 203.94 |
| 2022-03-31 | $198M | 940k | 210.60 |
| 2021-12-31 | $219M | 914k | 239.92 |
| 2021-09-30 | $156M | 550k | 282.99 |
| 2021-06-30 | $46M | 134k | 346.27 |
| 2021-03-31 | $48M | 173k | 279.75 |